EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Approaches for Targeting Naegleria fowleri Using Nanoparticles and Artificial Peptides

Hayley Fong iD, Zachary H Leid iD, Anjan Debnath iD

Pathogens · 2024

DOI: 10.3390/pathogens13080695 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2024. Verfasst von Hayley Fong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego,…. Hauptthemen laut MEDLINE: Naegleria fowleri, Blood-Brain Barrier, Central Nervous System Protozoal Infections, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Naegleria fowleri is a free-living amoeba which causes primary amoebic meningoencephalitis (PAM). Although PAM is rare, the fatality rate is staggering at over 97%. So, the importance of finding an effective treatment and cure for PAM caused by N. fowleri is a crucial area of research. Existing research on developing novel therapeutic strategies to counter N. fowleri infection is limited. Since the blood–brain barrier (BBB) presents an obstacle to delivering drugs to the site of infection, it is important to employ strategies that can effectively direct the therapeutics to the brain. In this regard, our review focuses on understanding the physiology and mechanisms by which molecules pass through the BBB, the current treatment options available for PAM, and the recent research conducted in the decade of 2012 to 2022 on the use of nanomaterials to enhance drug delivery. In addition, we compile research findings from other central nervous system (CNS) diseases that use shuttle peptides which allow for transport of molecules through the BBB. The approach of utilizing BBB shuttles to administer drugs through the BBB may open up new areas of drug discovery research in the field of N. fowleri infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Naegleria fowleriBlood-Brain BarrierCentral Nervous System Protozoal InfectionsNanoparticlesPeptidesDrug Delivery SystemsHumansAnimals

Stichwörter der Autor:innen

Naegleria fowleriblood–brain barrierfree-living amoebananomaterialsnanoparticlesprimary amoebic meningoencephalitisshuttle peptide

Substanzen

Peptides

Autor:innen und Institutionen

  • Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA.

ORCID-Profile: Hayley Fong, Zachary H Leid, Anjan Debnath

Förderung

  • NIAID NIH HHS
  • NIH

Zitieren

APA

Fong, H., Leid, Z. H., & Debnath, A. (2024). Approaches for Targeting Naegleria fowleri Using Nanoparticles and Artificial Peptides. Pathogens. https://doi.org/10.3390/pathogens13080695

Vancouver

Fong H, Leid ZH, Debnath A. Approaches for Targeting Naegleria fowleri Using Nanoparticles and Artificial Peptides. Pathogens. 2024. doi:10.3390/pathogens13080695

BibTeX
@article{Fong2024,
  author = {Fong, Hayley and Leid, Zachary H and Debnath, Anjan},
  title = {Approaches for Targeting Naegleria fowleri Using Nanoparticles and Artificial Peptides},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13080695}
}
Kostenlos starten →